Dirk O. Muegge

Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Rudolf A. Werner, Harun Ilhan, Sebastian Lehner et al. · Molecular Imaging and Biology · 2018 · 91 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity

Rudolf A. Werner, Constantin Lapa, Harun Ilhan et al. · Oncotarget · 2016 · 81 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment

Rudolf A. Werner, J Schmid, Dirk O. Muegge et al. · Medicine · 2015 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

Constantin Lapa, Rudolf A. Werner, Christina Bluemel et al. · EJNMMI Research · 2014 · 10 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17